Stubbs R J, Harker A J
Glaxo Research and Development Ltd, Greenford, Middlesex, UK.
J Chromatogr B Biomed Appl. 1995 Aug 18;670(2):279-85. doi: 10.1016/0378-4347(95)00165-4.
A pre-column fluorescence derivatisation high-performance liquid chromatographic method for the analysis of a neuraminidase inhibitor, GG167, in human serum is described. GG167 was extracted from serum samples using Bond Elut SCX solid-phase extraction cartridges, followed by derivatisation with benzoin prior to reversed-phase chromatography with fluorescence detection. This method has been automated using a Zymark robot and used in the analysis of human serum samples from clinical studies. The method has been shown to be valid over a concentration range of 10-800 ng/ml using a 1-ml sample volume.
本文描述了一种用于分析人血清中神经氨酸酶抑制剂GG167的柱前荧光衍生化高效液相色谱法。使用Bond Elut SCX固相萃取柱从血清样品中提取GG167,然后在进行反相色谱荧光检测之前用苯偶姻进行衍生化。该方法已使用Zymark机器人实现自动化,并用于临床研究中人类血清样品的分析。使用1 ml样品体积时,该方法在10 - 800 ng/ml的浓度范围内已被证明是有效的。